Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland
February 19, 2026Research and Development Siemens Healthineers
Siemens Healthineers has opened a new Centre of Excellence for Immunoassay Instrument Research & Development in Swords, Ireland. Over 10m …
Everdrone announces new board of directors to drive expansion
February 19, 2026Everdrone
Everdrone, a provider of autonomous drone systems for use in healthcare and emergency response, has appointed a new board of …
Regeneron announces presentations of new data on Eylea HD for retinal disease
February 18, 2026Research and Development Eylea HD, Opthalmology, Regeneron
Regeneron has presented data for Eylea HD (aflibercept) 8mg injection for retinal disease. The data was presented as part of …
Indegene completes acquisition of Cake Health
February 18, 2026Cake Health, Indegene
Indegene, a life sciences solutions company, has announced its acquisition of Cake Health, a healthcare agency, as well as its …
Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals
February 17, 2026Manufacturing and Production Gedeon Richter UK, Neurology
Gedeon Richter UK has announced its acquisition of full marketing and distribution rights to Reagila (cariprazine), a schizophrenia treatment, from …
ENA Respiratory doses first patients with INNA-051 antiviral nasal spray
February 17, 2026Ear Nose & throat, Ena Respiratory
ENA Respiratory, a clinical-stage biopharmaceutical company specialising in the prevention of viral respiratory infections, has announced the first dosing of …
New medtech company Carvolix created as Affluent Medical acquires Caranx Medical and Artedrone
February 16, 2026Research and Development Cardiology, Carvolix
Carvolix (formerly Affluent Medical), a commercial and clinical-stage biotechnology company developing AI-powered mini-robots and biomimetic implants, has completed the acquisition …
Qlaris Bio appoints Robert Warner to board of directors
February 16, 2026Qlaris Bio
Qlaris Bio has appointed Robert Warner to its board of directors. Warner brings significant experience in life sciences leadership to …
Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation
February 12, 2026Research and Development Cardiology, Rhythm AI, atrial fibrillation
Rhythm AI, a UK-based company specialising in atrial fibrillation procedures, has announced that its STAR Apollo Mapping System has received …
iOrganBio appoints Karol Jarzabek as Chief Operating Officer
February 12, 2026Manufacturing and Production iOrganBio
iOrganBio has announced the appointment of Karol Jarzabek as Chief Operating Officer (COO). Jarzabek specialises in operational management and business …
Ensera Design expands UK leadership team with new senior appointments
February 11, 2026Business Services, Consultancy Ensera Design
Ensera Design, a healthcare product innovation consultancy, has announced the expansion of its UK leadership team with multiple new appointments. …
Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine
February 11, 2026Research and Development Infinitopes, Oncology
Infinitopes, a clinical stage biotechnology company specialising in oncology, has announced the receipt of an additional $15.4m in seed funding, …
Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer
February 10, 2026Angelini Pharma
Angelini Pharma, the pharmaceutical branch of Angelini Industries, has announced the appointment of Roberto Scrivo as Chief of External Affairs, …
Hongene Biotech receives Gates Foundation grant to drive mRNA vaccine production
February 10, 2026Manufacturing and Production Hongene Biotech, mRNA vaccine
Hongene Biotech, a contract development and manufacturing organisation (CDMO) and ribonucleic acid (RNA) technology provider, has announced the receipt of …
BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer
February 5, 2026Research and Development BMS, Scottish Medicines Consortium, colorectal cancer, oncology
Bristol Myers Squibb (BMS) has announced that its Opdivo (nivolumab) has been accepted, in combination with Yervoy (ipilimumab), by the …
AstronauTx appoints Adam Rosenberg as Chair of the Board
February 5, 2026AstronauTx, chair of the board
AstronauTx has announced the appointment of Adam Rosenberg as Chair of its Board of Directors. Rosenberg’s leadership experience includes holding …
Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer
February 4, 2026Research and Development Astellas Pharma, Scottish Medicines Consortium, Vyloy, gastric cancer, oncology
Astellas Pharma, a pharmaceutical company creating medicines to address unmet medical needs, has announced that Vyloy (zolbetuximab), in combination with …
Angelini Pharma appoints Sergio Marullo di Condojanni as CEO
February 4, 2026Angelini Pharma, CEO
Angelini Pharma, a branch of Angelini Industries, has announced the appointment of Sergio Marullo di Condojanni as CEO. Marullo di …
QV Bioelectronics secures £4.5m in funding for brain cancer therapy development
February 3, 2026Research and Development Oncology, QV Bioelectronics, glioblastoma
QV Bioelectronics, a medtech business specialising in implants for cancer treatment, has announced that it has received £4.5m in funding …
Alvotech appoints Lisa Graver as CEO
February 3, 2026Alvotech, CEO
Alvotech has announced the appointment of Lisa Graver as CEO, following the retirement of Róbert Wessman. Wessman served as Chairman …
Latest content
FibroFind appoints Lee Borthwick as CEO
